99690
Anagrelide controlled release ( GALE-401 ) is in phase III clinical trials by Galena Biopharma for the treatment of essential thrombocytosis .
 Galena Biopharma
Please list all entity words in the text that fit the category. Output format is "word1, word2". 
Option: media, plant, vehicle, astronomical object, time, disease, animal, location, person, organization, mythical figure, food, biology, geographical phenomenon, instrument, event 
Text: {0} 
Answer:
 Galena Biopharma